Literature DB >> 21965079

Molecular modeling study on the disassembly of dendrimers designed as potential antichagasic and antileishmanial prodrugs.

Jeanine Giarolla1, Kerly F M Pasqualoto, Daniela G Rando, Márcio H Zaim, Elizabeth I Ferreira.   

Abstract

A molecular modeling study was carried out to investigate the most likely enzymatic disassembly mechanism of dendrimers that were designed as potential antichagasic and antileishmanial prodrugs. The models contained myo-inositol (core), L-malic acid (spacer), and active agents such as 3-hydroxyflavone, quercetin, and hydroxymethylnitrofurazone (NFOH). A theoretical approach that considered one, two, or three branches has already been performed and reported by our research group; the work described herein focused on four (models A and B), five, or six branches, and considered their physicochemical properties, such as spatial hindrance, electrostatic potential mapping, and the lowest unoccupied molecular orbital energy (E(LUMO)). The findings suggest that the carbonyl group next to the myo-inositol is the most promising ester breaking point.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21965079     DOI: 10.1007/s00894-011-1244-8

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  26 in total

1.  Designing dendrimers for drug delivery.

Authors: 
Journal:  Pharm Sci Technol Today       Date:  1999-10

Review 2.  Challenges and new discoveries in the treatment of leishmaniasis.

Authors:  Sarman Singh; Ramu Sivakumar
Journal:  J Infect Chemother       Date:  2004-12       Impact factor: 2.211

Review 3.  Neglected tropical diseases in Brazil.

Authors:  José Angelo L Lindoso; Ana Angélica B P Lindoso
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2009 Sep-Oct       Impact factor: 1.846

4.  Prediction of ligand-receptor binding thermodynamics by free energy force field (FEFF) 3D-QSAR analysis: application to a set of peptidometic renin inhibitors.

Authors:  J S Tokarski; A J Hopfinger
Journal:  J Chem Inf Comput Sci       Date:  1997 Jul-Aug

5.  In vitro evaluation of dendrimer prodrugs for oral drug delivery.

Authors:  Mohammad Najlah; Sally Freeman; David Attwood; Antony D'Emanuele
Journal:  Int J Pharm       Date:  2006-11-28       Impact factor: 5.875

6.  Structural and mechanistic studies of Escherichia coli nitroreductase with the antibiotic nitrofurazone. Reversed binding orientations in different redox states of the enzyme.

Authors:  Paul R Race; Andrew L Lovering; Richard M Green; Abdelmijd Ossor; Scott A White; Peter F Searle; Christopher J Wrighton; Eva I Hyde
Journal:  J Biol Chem       Date:  2005-01-31       Impact factor: 5.157

Review 7.  Leishmaniasis.

Authors:  B L Herwaldt
Journal:  Lancet       Date:  1999-10-02       Impact factor: 79.321

Review 8.  Leishmaniasis treatment--a challenge that remains: a review.

Authors:  Dilvani O Santos; Carlos E R Coutinho; Maria F Madeira; Carolina G Bottino; Rodrigo T Vieira; Samara B Nascimento; Alice Bernardino; Saulo C Bourguignon; Suzana Corte-Real; Rosa T Pinho; Carlos Rangel Rodrigues; Helena C Castro
Journal:  Parasitol Res       Date:  2008-06       Impact factor: 2.289

9.  Epidemiology, control and surveillance of Chagas disease: 100 years after its discovery.

Authors:  José Rodrigues Coura; João Carlos Pinto Dias
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

Review 10.  Dendrimers as versatile platform in drug delivery applications.

Authors:  Sonke Svenson
Journal:  Eur J Pharm Biopharm       Date:  2008-10-17       Impact factor: 5.571

View more
  2 in total

1.  Intracellular Iron Binding and Antioxidant Activity of Phytochelators.

Authors:  Fredson Torres Silva; Breno Pannia Espósito
Journal:  Biol Trace Elem Res       Date:  2021-10-14       Impact factor: 3.738

Review 2.  Drug/Lead Compound Hydroxymethylation as a Simple Approach to Enhance Pharmacodynamic and Pharmacokinetic Properties.

Authors:  Soraya S Santos; Rodrigo V Gonzaga; Cauê B Scarim; Jeanine Giarolla; Marina C Primi; Chung M Chin; Elizabeth I Ferreira
Journal:  Front Chem       Date:  2022-02-14       Impact factor: 5.221

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.